Email Updates

Search form

You are here

AVAC's Blog: P-Values

  • In July, AVAC and Internews in Kenya organized a journalists briefing on PrePex, a non-surgical device for voluntary medical male circumcision (VMMC) pre-qualified by the World Health Organization (WHO). (Click here for more on this process.) This was the first in a planned series of journalist “cafés” designed to spark conversation about VMMC and the role of non-surgical devices.

    October 30, 2013
  • The Good Participatory Practice Guidelines continue to be rolled out in various contexts and are increasingly seen as an essential tool for engaging stakeholders in research. In recent months, AVAC collaborated with partners in Kenya, South African and Uganda for focused feedback sessions about several new GPP implementation tools that are in the works. The new tools take users through the process of developing a strategic community and stakeholder engagement plan.

    October 29, 2013
    General
  • Lillian Mworeko from ICW-East Africa and an AVAC Fellowship Host Supervisor in 2012 gave a dynamic presentation on the June 11 USAID/FHI 360 webinar “Hormonal Contraception and HIV: What Do the Evidence and WHO Technical Statement Mean for Programs?” Mworeko highlighted the critical importance of addressing women’s reproductive health and HIV prevention and/or treatment needs with integrated services that provide full information on the risks and benefits of all available options—including injectable hormonal contraceptives.

    June 30, 2013
  • On June 19-20 in Kigali, 15 civil society organizations (CSOs) completed a two-day training on HIV prevention with a focus on pre-exposure prophylaxis (PrEP). The meeting was organized by 2013 AVAC Prevention Research Advocacy Fellow Josephine Kamarebe and her host organization, the Health Development Initiative.

    June 20, 2013
  • On June 18, AVAC, the Mail & Guardian’s Bhekisisa Centre for Health Journalism and CAPRISA held a media briefing on non-surgical devices for voluntary medical male circumcision (VMMC). This meeting helped contextualize the recent World Health Organization (WHO) prequalification of the PrePex device and took place in advance of the South African AIDS Conference (SAAIDS) in Durban, South Africa.

    June 18, 2013
  • AVAC hosted a two-day training "Rave" at its New York office in April. This annual workshop brings together US-based advocates from AVAC's PxROAR (Prevention Research Outreach Advocacy and Representation) program for an intensive update on the latest in the field of biomedical HIV prevention research and implementation, and provides a space for advocacy strategizing. This year's focus was on treatment as prevention and pre-exposure prophylaxis (PrEP).

    May 31, 2013
  • Each year on May 18, the global HIV/AIDS community commemorates HIV Vaccine Awareness Day (HVAD). This year, AVAC worked with civil society and research partners from across the globe on a number of community events to mark the date.

    May 18, 2013
  • PxROAR member Nichole Little talks about her recent work with PxROAR colleague Robert Newells.

    For years here in Oakland, CA, community health advocates have tried everything to get ahead of the curve on HIV transmission. When presented with a new tool, pre-exposure prophylaxis (PrEP), my fellow PxROAR member Robert Newells and I were eager to take advantage. To better understand how our community could implement PrEP we planned a series of local meetings on the subject.

    April 30, 2013
  • Last month, the AVAC Advocacy Fellowship 2012 Wrap-up & 2013 Orientation Workshop took place in Cape Town, South Africa. The three-day gathering provided an opportunity for the 2012 Fellows to present their projects, reflect on the program and discuss their future work as advocates. The 2013 Fellows and their host organization supervisors were oriented to the specifics of the program and discussed their proposed projects for their Fellowship year.

    April 30, 2013
    General
    AVAC
  • In January AVAC collaborated with the French AIDS organization Sidaction to host a meeting, Challenges of clinical trial design, degree of evidence and recommendations in the era of PrEP. The meeting provided a forum for local French researchers and advocates to discuss IPERGAY, the intermittent PrEP study currently underway with men who have sex with men in France. A number of international researchers, advocates and normative agencies were also on hand to broaden the discussion.

    April 30, 2013

Pages